Catalina Capital Group, LLC Abb Vie Inc. Transaction History
Catalina Capital Group, LLC
- $153 Billion
- Q1 2025
A detailed history of Catalina Capital Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Catalina Capital Group, LLC holds 3,249 shares of ABBV stock, worth $590,668. This represents 0.44% of its overall portfolio holdings.
Number of Shares
3,249
Previous 10,670
69.55%
Holding current value
$590,668
Previous $1.9 Billion
64.09%
% of portfolio
0.44%
Previous 0.62%
Shares
6 transactions
Others Institutions Holding ABBV
# of Institutions
4,259Shares Held
1.27BCall Options Held
18.2MPut Options Held
15.5M-
Vanguard Group Inc Valley Forge, PA174MShares$31.6 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$24.8 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$14.5 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$9.95 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.48 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $321B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...